Knowledge Hub:
Thought Leadership

Found: 12 Items

As Drug Delivery Evolves, So Must Patient Training

Higher-dose and larger-volume subcutaneous therapies are creating new possibilities for drug delivery, including programs exploring the transition from intravenous (IV) to subcutaneous (SC) administration. A 2024 systematic review identified 182 clinical-stage or approved large-volume SC biopharmaceuticals, defined by the authors as doses greater than 2 mL, spanning oncology and a range of chronic disease areas.

Beyond the Device: Key Takeaways from PDA PFS 2026

The 2026 PDA Universe of Pre-Filled Syringes and Injection Devices Conference brought the drug delivery community together in Palm Springs around the theme, “Where Molecules Meet Devices: Advancing Patient-Centric Solutions.” Across the program, the intersection of drug delivery, device development, combination products, technology and user experience was front and center.

Download Noble’s Integrated Advantage Report

Download the report to discover how pharmaceutical organizations can move beyond fragmented execution and create a stronger foundation for launch success, patient confidence, and long-term therapy adherence.

Keep ahead of pharmaceutical demand

Device Differences Matter: Why Addressing Negative Transfer Is Critical to Biosimilar Success

As biosimilar and interchangeable biologic therapies continue to expand patient access to treatment, the industry has an opportunity to focus on more than affordability and availability. The patient experience must remain a priority, particularly as new delivery devices enter the market.

What an Entrepreneurial Mindset Means in Pharma and Medical Device Development

Innovation is a constant in pharma and medical device development. But what separates true industry leaders is not just innovation—it’s an entrepreneurial mindset.

Noble’s Integrated Model

Download the infographic to see how an integrated approach can simplify the patient journey and support confidence from device strategy through long-term adherence.

How Pharma Teams Should Approach Autoinjector Device Selection and Design Strategy

Learn how pharma teams should approach autoinjector device selection and autoinjector design strategy using patient-first insights, human factors, and real-world use to reduce risk and improve adherence.

Video: Reimagining the Patient Experience

Image of a variety of platform training devices across different therapeutic areas.

Platform vs. Custom Training Devices: Choosing the Right Approach for Your Brand

Choosing the right training device shapes the patient experience by building familiarity, confidence, and comfort with self-administration.

patient holding training device

Autoinjectors: Innovation in Self-Administered Training Devices

The rapid pace of technological advancements has dramatically transformed the medical field. This ushers in a new era of innovative solutions that have…

Revolutionizing Healthcare: The Rise of Self-Injection Training Devices

Revolutionizing Healthcare: The Rise of Self-Injection Training Devices

Autoinjectors are a crucial mode of drug delivery, expanding access to care by allowing patients to manage their health conditions independently and…

woman with inhaler

The Importance of Training and Onboarding for Intranasal Rescue Therapies

Nasal drug repurposing has seen a real resurgence recently, driven by several factors. From an economic perspective, partners benefit from reduced…